dr. Bram De Laere
- ORCID iD
- 0000-0002-1174-0384
Show
Sort by
-
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
-
- Journal Article
- A1
- open access
AR and PI3K genomic profiling of cell-free DNA can identify poor responders to Lutetium-177-PSMA among patients with metastatic castration-resistant prostate cancer
-
WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer
-
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
-
- Journal Article
- A1
- open access
Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma
-
- Journal Article
- A1
- open access
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer
-
- Journal Article
- A1
- open access
Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer
-
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review
-
- Conference Paper
- C3
- open access
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach
-
- Journal Article
- A1
- open access
The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
-
Inferring the genomic landscape of lymph-node positive high-risk prostate cancer